| Date Filed | Type | Description |
| 12/05/2022 |
4
| Lo Andrew (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Granted 47,231 options to buy
@ $13.18, valued at
$622.5k
|
|
| 09/19/2022 |
4
| Lo Andrew (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Granted 52,142 shares
@ $0
Granted 71,850 options to buy
@ $3.5, valued at
$251.5k
|
|
| 06/24/2022 |
4
| Lo Andrew (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 104,921 options to buy
@ $8.45, valued at
$886.6k
|
|
| 01/03/2022 |
4
| Lo Andrew (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Bought 6,000 shares
@ $12.9, valued at
$77.4k
Bought 1,500 shares
@ $14.3, valued at
$21.5k
|
|
| 12/10/2021 |
4/A
| Lo Andrew (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Granted 91,325 options to buy
@ $14.02, valued at
$1.3M
|
|
| 12/07/2021 |
4
| Lo Andrew (Director) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Bought 86,938 shares
@ $14.02, valued at
$1.2M
|
|
| 12/07/2021 |
3
| Lo Andrew (Director) has filed a Form 3 on AbCellera Biologics Inc. |
| 10/01/2021 |
3
| Lo Andrew (Director) has filed a Form 3 on Roivant Sciences Ltd. |
| 06/22/2021 |
4
| Lo Andrew (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 38,895 options to buy
@ $62.63, valued at
$2.4M
|
|
| 06/25/2020 |
4
| Lo Andrew (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 101,223 options to buy
@ $32.62, valued at
$3.3M
|
|
| 06/25/2020 |
3
| Lo Andrew (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 07/15/2019 |
4
| Lo Andrew (Former 10% Owner) has filed a Form 4 on Myovant Sciences Ltd. |
| 07/15/2019 |
4
| Lo Andrew (Former 10% Owner) has filed a Form 4 on Urovant Sciences Ltd. |
| 07/15/2019 |
4
| Lo Andrew (Former 10% Owner) has filed a Form 4 on Axovant Gene Therapies Ltd. |
| 07/15/2019 |
4
| Lo Andrew (Former 10% Owner) has filed a Form 4 on Arbutus Biopharma Corp |
| 06/19/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,541 shares
@ $8.5346, valued at
$55.8k
Bought 6,706 shares
@ $8.2107, valued at
$55.1k
Bought 4,957 shares
@ $8.1693, valued at
$40.5k
|
|
| 06/14/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $8.2992, valued at
$62.2k
Bought 7,367 shares
@ $7.9466, valued at
$58.5k
Bought 7,144 shares
@ $7.9107, valued at
$56.5k
|
|
| 06/14/2019 |
SC 13D
| Lo Andrew reports a 45.6% stake in Myovant Sciences Ltd. |
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 7,500 shares
@ $7.5881, valued at
$56.9k
Bought 6,540 shares
@ $8.015, valued at
$52.4k
Bought 7,082 shares
@ $7.9951, valued at
$56.6k
|
|
| 06/06/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Bought 2,424,242 shares
@ $8.25, valued at
$20M
|
|
| 06/03/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 6,951 shares
@ $7.9726, valued at
$55.4k
Bought 300 shares
@ $8.9066, valued at
$2.7k
Bought 5,071 shares
@ $7.6991, valued at
$39k
Bought 5,424 shares
@ $7.7092, valued at
$41.8k
|
|
| 05/29/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 3,796 shares
@ $7.7011, valued at
$29.2k
Bought 3,807 shares
@ $7.6818, valued at
$29.2k
Bought 6,882 shares
@ $7.5535, valued at
$52k
|
|
| 05/23/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 9,995 shares
@ $8.5151, valued at
$85.1k
Bought 5,033 shares
@ $8.0584, valued at
$40.6k
Bought 4,802 shares
@ $7.7576, valued at
$37.3k
|
|
| 05/20/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 5,408 shares
@ $6.7896, valued at
$36.7k
Bought 6,200 shares
@ $7.3615, valued at
$45.6k
Bought 8,285 shares
@ $7.9833, valued at
$66.1k
Bought 1,715 shares
@ $8.3867, valued at
$14.4k
|
|
| 03/19/2019 |
SC 13D/A
| Lo Andrew reports a 58.2% stake in Axovant Sciences Ltd. |
| 03/19/2019 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Bought 6,666,667 shares
@ $1.5, valued at
$10M
|
|
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/20/2018 |
SC 13D/A
| Lo Andrew reports a 65.2% stake in Axovant Sciences Ltd. |
| 12/20/2018 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Bought 10,000,000 shares
@ $1, valued at
$10M
|
|
| 10/10/2018 |
SC 13D
| Lo Andrew reports a 75.6% stake in Urovant Sciences Ltd. |
| 10/03/2018 |
4
| Lo Andrew (10% Owner) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 2,678,571 shares
@ $14, valued at
$37.5M
|
|
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/07/2018 |
SC 13D/A
| Lo Andrew reports a 73.1% stake in Axovant Sciences Ltd. |
|